National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Closed Meeting, 28833-28834 [2019-13065]
Download as PDF
<![CDATA[
Federal Register / Vol. 84, No. 119 / Thursday, June 20, 2019 / Notices
factor authentication for computer
access; and securing areas where
records are stored. Job-specific assigned
roles control the release of data only to
authorized users. All users of personal
information in connection with the
performance of their jobs protect
information from public view and
unauthorized personnel entering an
unsupervised office.
4. Risk assessment: Risk assessments
and continuous monitoring activities
ensure that vulnerabilities, risks, and
other security concerns are identified
and addressed in the system design and
throughout the life cycle of the project.
RECORD ACCESS PROCEDURES:
Record access procedures are the
same as Requests in Person procedures
below.
CONTESTING RECORD PROCEDURES:
jbell on DSK3GLQ082PROD with NOTICES
To contest a record in the system,
contact the System Manager at the
address specified above and reasonably
identify the record, stipulate the
information being contested, state the
corrective action sought and the
reason(s) for requesting the correction,
along with supporting documentation to
show how the record is inaccurate,
incomplete, untimely, or irrelevant.
verify his/her identity. If an individual
does not have identification papers to
verify identity, (s)he must certify in
writing that (s)he is the individual (s)he
claims to be and that (s)he understands
that the knowing and willful request for,
or acquisition of, a record pertaining to
an individual under false pretenses is a
criminal offense subject to a $5,000 fine.
Requests on behalf of a minor/legally
incompetent person: A parent or
guardian who makes a request on behalf
of a minor/legally incompetent person
must verify his/her relationship to the
minor/legally incompetent person as
well as his/her own identity. If
requesting a minor or legally
incompetent person’s medical records,
the parent or guardian of a minor/legally
incompetent person must designate a
family physician or other health
professional (other than a family
member) to whom the records, if any,
will be sent.
Requests by telephone/facsimile/
electronic mail: Since positive
identification of the requester cannot be
established, telephone, facsimile, or
electronic mail (email) requests will not
be honored.
EXEMPTIONS PROMULGATED FOR THE SYSTEM:
None.
NOTIFICATION PROCEDURES:
HISTORY:
Requests must be made to the System
Manager.
Requests by mail: Requests for
information and/or access to records
received by mail must contain
information providing the identity of
the writer, and a reasonable description
of the record desired, and who it
concerns. Written requests must contain
the name and address of the requester,
his/her date of birth and his/her
signature for comparison purposes.
Requests must be notarized to verify the
identity of the requester, or the
requester must certify that (s)he is the
individual who (s)he claims to be and
that (s)he understands that to knowingly
and willfully request or acquire a record
pertaining to another individual under
false pretenses is a criminal offense
under the Privacy Act subject to a
$5,000 fine. The requester should
provide a reasonable description of the
contents of the record being sought.
Records will be mailed only to the
requester’s address that is on file unless
a different address is demonstrated by
official documentation.
Requests in person: An individual
who makes a request in person shall
provide to the System Manager at least
one piece of tangible identification such
as a driver’s license, passport, alien or
voter registration card, or union card to
75 FR 60468 (Sept. 30, 2010), 83 FR
6591 (Feb. 14, 2018).
VerDate Sep<11>2014
17:47 Jun 19, 2019
Jkt 247001
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel; Career Development
(Ks), Conference (R13) and Research
Education (R25) Applicants Review.
Date: July 18, 2019.
Time: 9:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, Suite 920, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: John P. Holden, Ph.D.,
Scientific Review Officer, National Institute
of Biomedical Imaging and Bioengineering,
National Institutes of Health, 6707
Democracy Boulevard, Suite 920, Bethesda,
MD 20892, 301–496–8775, john.holden@
nih.gov.
Dated: June 14, 2019.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–13062 Filed 6–19–19; 8:45 am]
Notice of Rescindment
For the reason explained in the
SUPPLEMENTARY INFORMATION section at
II., the following system of records is
rescinded:
BILLING CODE 4140–01–P
SYSTEM NAME AND NUMBER:
National Institutes of Health
Countermeasures Injury
Compensation Program, HHS/HRSA/
HSB, 09–15–0071.
HISTORY:
76 FR 28991 (May 19, 2011), 83 FR
6591 (Feb. 14, 2018).
[FR Doc. 2019–13091 Filed 6–19–19; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel.
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
28833
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institute of Arthritis and
Musculoskeletal and Skin Diseases;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Arthritis and Musculoskeletal and Skin
Diseases Special Emphasis Panel; BACPAC
U24 Review.
E:\FR\FM\20JNN1.SGM
20JNN1
28834
Federal Register / Vol. 84, No. 119 / Thursday, June 20, 2019 / Notices
Date: July 18, 2019.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, One
Democracy Plaza, 6701 Democracy
Boulevard, Bethesda, MD 20892.
Contact Person: Kan Ma, Ph.D., Scientific
Review Officer, Scientific Review Branch,
National Institute of Arthritis,
Musculoskeletal and Skin Diseases, NIH,
6701 Democracy Boulevard, Suite 814,
Bethesda, MD 20892, 301–451–4838, mak2@
mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.846, Arthritis,
Musculoskeletal and Skin Diseases Research,
National Institutes of Health, HHS)
Dated: June 14, 2019.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–13065 Filed 6–19–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Closed Meeting
jbell on DSK3GLQ082PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel; P41 BTRC Review B
SEP.
Date: July 8–10, 2019.
Time: 6:00 p.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Sheraton Imperial Hotel RaleighDurham Airport, 4700 Emperor Blvd.,
Durham, NC 27703.
VerDate Sep<11>2014
17:47 Jun 19, 2019
Jkt 247001
Contact Person: Ruixia Zhou, Ph.D.,
Scientific Review Officer, 6707 Democracy
Boulevard, Democracy Two Building,
National Institutes of Health, Suite 957,
Bethesda, MD 20892, 301–496–4773, zhour@
mail.nih.gov.
Dated: June 14, 2019.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–13064 Filed 6–19–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Deafness and
Other Communication Disorders;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Deafness and Other Communication
Disorders Special Emphasis Panel; Clinical
Research Center Review.
Date: July 9, 2019.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center Building (NSC), 6001
Executive Boulevard, Rockville, MD 20852
(Telephone Conference Call).
Contact Person: Eliane Lazar-Wesley,
Ph.D., Scientific Review Officer, Scientific
Review Branch, Division of Extramural
Activities, 6001 Executive Boulevard, Room
8339, MSC 9670, Bethesda, MD 20892–8401,
301–496–8683, el6r@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.173, Biological Research
Related to Deafness and Communicative
Disorders, National Institutes of Health, HHS)
Dated: June 14, 2019.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–13063 Filed 6–19–19; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
Mechanisms of Disparities in Chronic Liver
Diseases and Cancer.
Date: July 9, 2019.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Delia Olufokunbi Sam,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3158,
MSC 7770, Bethesda, MD 20892, 301–435–
0684, olufokunbisamd@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Panel Name:
Molecular and Cellular Causal Aspects of
Alzheimer’s Disease.
Date: July 10, 2019.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Afia Sultana, Ph.D.,
Scientific Review Officer, National Institutes
of Health, Center for Scientific Review, 6701
Rockledge Drive, Room 4189, Bethesda, MD
20892, (301) 827–7083, sultanaa@
mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Cardiovascular Small Business.
Date: July 11, 2019.
Time: 8:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Wyndham Grand Chicago
Riverfront, 71 E Wacker Dr., Chicago, IL
60601.
Contact Person: Margaret Chandler, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4126,
E:\FR\FM\20JNN1.SGM
20JNN1
]]>Agencies
[Federal Register Volume 84, Number 119 (Thursday, June 20, 2019)]
[Notices]
[Pages 28833-28834]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-13065]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Arthritis and Musculoskeletal and Skin
Diseases; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Arthritis and
Musculoskeletal and Skin Diseases Special Emphasis Panel; BACPAC U24
Review.
[[Page 28834]]
Date: July 18, 2019.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, One Democracy Plaza, 6701
Democracy Boulevard, Bethesda, MD 20892.
Contact Person: Kan Ma, Ph.D., Scientific Review Officer,
Scientific Review Branch, National Institute of Arthritis,
Musculoskeletal and Skin Diseases, NIH, 6701 Democracy Boulevard,
Suite 814, Bethesda, MD 20892, 301-451-4838, [email protected].
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
(Catalogue of Federal Domestic Assistance Program Nos. 93.846,
Arthritis, Musculoskeletal and Skin Diseases Research, National
Institutes of Health, HHS)
Dated: June 14, 2019.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-13065 Filed 6-19-19; 8:45 am]
BILLING CODE 4140-01-P
